As of Jan 17
| -0.02 / -0.42%|
The 6 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 6.50, with a high estimate of 12.00 and a low estimate of 5.75. The median estimate represents a +35.98% increase from the last price of 4.78.
The current consensus among 7 polled investment analysts is to Buy stock in Pacific Biosciences of California Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.